-
11161por Yang, Si, Yao, Bowen, Wu, Liming, Liu, Yuanxing, Liu, Kang, Xu, Peng, Zheng, Yi, Deng, Yujiao, Zhai, Zhen, Wu, Ying, Li, Na, Zhang, Dai, Kang, Huafeng, Dai, Zhijun“…Cluster 2 had better prognosis than did cluster 1. Hepatitis B, hepatitis C, Janus tyrosine kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, and natural killer cell-mediated cytotoxicity were enriched in cluster 1. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11162por Boeckmans, Joost, Rombaut, Matthias, Demuyser, Thomas, Declerck, Baptist, Piérard, Denis, Rogiers, Vera, De Kock, Joery, Waumans, Luc, Magerman, Koen, Cartuyvels, Reinoud, Rummens, Jean-Luc, Rodrigues, Robim M., Vanhaecke, Tamara“…We focus in particular on how infectious diseases, including coronavirus disease-19, hepatitis C, acquired immunodeficiency syndrome, peptic ulcer and periodontitis, exacerbate MAFLD. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11163por Lamoury, Francois M. J., Njouom, Richard, Amougou-Atsama, Marie, Yiagnigni Mfopou, Euloge, Berishvili, Nino, Sologashvili, Manana, Fajardo, Emmanuel, Malobela, Agnes, Macé, Aurélien, Chirehwa, Maxwell, Alkhazashvili, Maia, Ivanova Reipold, Elena“…Point-of-care diagnostics have the potential to increase diagnosis and linkage to care and help reach the WHO targets to eliminate hepatitis C virus (HCV) by 2030. Here, we evaluated the diagnostic accuracy of Genedrive HCV ID assay for the qualitative detection of HCV RNA in decentralized settings in two low- and middle-income countries using fresh plasma specimens from 426 participants. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11164“…Hepatitis C virus-associated HCC (HCV-HCC) is a prevalent malignancy worldwide and the molecular mechanisms are still elusive. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11165“…By generating large sets of stochastic trajectories, which are individually designed to mimic the molecular dynamics crossing statistics of models of channels of trichotoxin, p7 from hepatitis C and a bacterial homolog of the pentameric ligand-gated ion channel, GLIC, we find that the free energy profiles obtained from stochastic simulations corresponding to molecular dynamics simulations of even a modest length are burdened with statistical errors of only 0.3 kcal/mol. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11166por Ciurea, Ana-Maria, Gheonea, Dan Ionuț, Schenker, Michael, Mehedințeanu, Alina Maria, Târtea, Georgică Costinel, Vere, Cristin Constantin“…The univariate analysis revealed that an age > 60 years, hepatitis C, portal vein involvement (thrombosis), a tumor size > 5 cm, alpha-fetoprotein (AFP) > 400 ng/mL, serum albumin, and C-reactive protein (CRP) were risk factors for poor OS. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11167“…To do that, we first survey two well studied RdRps from Polio virus and hepatitis C virus in regard to structural motifs and key residues that have been identified for the nucleotide selectivity. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11168“…In this study, a cost‐effective purification process was developed for two chimeric HBc VLPs displaying Epstein–Barr nuclear antigens 1 (EBNA1), and hepatitis C virus (HCV) core. Both chimeric VLPs were expressed in soluble form with high production yields in Escherichia coli. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11169“…It has no cross‐reaction with other pathogens such as hepatitis b virus (HBV), hepatitis c virus (HCV), human papillomavirus (HPV), Epstein‐Barr virus (EBV), herpes simplex virus (HSV), cytomegalovirus (CMV), and human immunodeficiency virus (HIV). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11170“…Combined detection of HCV‐cAg and antibody serology can help doctors detect HCV infection earlier, accurately diagnose different stages of HCV infection, and evaluate the therapeutic effect of antiviral drugs, which are beneficial in the prevention and treatment of hepatitis C.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11171por Frost, Madeline C., Sweek, Elsa W., Austin, Elizabeth J., Corcorran, Maria A., Juarez, Alexa M., Frank, Noah D., Prohaska, Stephanie M., LaKosky, Paul A., Asher, Alice K., Broz, Dita, Jarlais, Don C. Des, Williams, Emily C., Glick, Sara N.“…Respondents discussed urgent concerns including reduced reach of services, suspended HIV/hepatitis C testing, high COVID-19 risk among PWUD, and negative impacts of isolation on overdose and mental health. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11172por Damavandi, Fereshte, Wang, Weiwei, Shen, Wei-Zheng, Cetinel, Sibel, Jordan, Tracy, Jovel, Juan, Montemagno, Carlo, Wong, Gane Ka-Shu“…Our method was tested against commercial capture assays using streptavidin beads, on a set of probes derived from a common genotype of the hepatitis C virus. We showed that our method is more specific and sensitive, most likely due to the combination of an inert silica coating and a high density of DNA probes clicked to the nanoparticles. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11173por Minosse, Claudia, Gruber, Cesare E. M., Rueca, Martina, Taibi, Chiara, Zaccarelli, Mauro, Grilli, Elisabetta, Montalbano, Marzia, Capobianchi, Maria R., Antinori, Andrea, D’Offizi, Gianpiero, McPhee, Fiona, Garbuglia, Anna Rosa“…The risk of hepatitis C virus (HCV) recurrence after direct-acting antiviral (DAA) treatment is <0.5%. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11174por Poulsen, Kyle L., Fan, Xiude, Kibler, Christopher D., Huang, Emily, Wu, Xiaoqin, McMullen, Megan R., Leng, Lin, Bucala, Richard, Ventura-Cots, Meritxell, Argemi, Josepmaria, Bataller, Ramon, Nagy, Laura E.“…Selected C-X-C chemokine members of the IL-8 chemokine family and C-C chemokine CCL20 were highly associated with AH compared with HC but not in patients with liver diseases of other etiologies (nonalcoholic fatty liver disease [NAFLD] and hepatitis C virus [HCV]). Our previous studies implicate macrophage migration inhibitory factor (MIF) as a pleiotropic cytokine/chemokine with the potential to coordinately regulate chemokine expression in AH. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11175por BALABAN, H. Yasemin, ASLAN, Abdullah Tarık, AYAR, Şefika, DAĞ, Osman, ALP, Alpaslan, ŞİMŞEK, Cem, VAHABOV, Cavanşir, YILDIRIM, Tolga, GÖKER, Hakan, BÜYÜKAŞIK, Yahya, ŞİMŞEK, Halis“…This study aimed to investigate the screening, immunization, and vaccination rates in three high-risk groups for HBV infection: allogeneic hematopoietic stem cell transplantation (AHSCT), renal transplantation (RT), and chronic hepatitis C (CHC) groups. MATERIALS AND METHODS: The serological data of consecutive patients between 2014 and 2019 were reviewed using the hospital database. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11176por Venkataraman, Srividhya, Hefferon, Kathleen, Makhzoum, Abdullah, Abouhaidar, Mounir“…Importantly, plant-made biopharmaceuticals against hepatitis B virus (HBV), hepatitis C virus (HCV), the cancer-causing virus human papillomavirus (HPV), human immunodeficiency virus (HIV), influenza virus, zika virus, and the emerging respiratory virus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been discussed. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11177por Pisano, María B, Giadans, Cecilia G, Flichman, Diego M, Ré, Viviana E, Preciado, María V, Valva, Pamela“…In the case of hepatitis B virus, we will discuss host factors related to disease, diagnosis, therapy, and vaccine improvement. On hepatitis C virus, we will focus on pathogenesis, immune response, direct action antivirals treatment in the context of solid organ transplantation, issues related to hepatocellular carcinoma development, direct action antivirals resistance due to selection of resistance-associated variants, and vaccination. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11178por Wang, Xuanting, Sacramento, Carolina Q., Jockusch, Steffen, Chaves, Otávio Augusto, Tao, Chuanjuan, Fintelman-Rodrigues, Natalia, Chien, Minchen, Temerozo, Jairo R., Li, Xiaoxu, Kumar, Shiv, Xie, Wei, Patel, Dinshaw J., Meyer, Cindy, Garzia, Aitor, Tuschl, Thomas, Bozza, Patrícia T., Russo, James J., Souza, Thiago Moreno L., Ju, Jingyue“…Here we report the identification of hepatitis C virus NS5A inhibitors Pibrentasvir and Ombitasvir as SARS-CoV-2 exonuclease inhibitors. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11179“…Hepatitis B virus and hepatitis C virus are transmitted by exposure to infected blood, and in addition to acute infection, they can cause chronic hepatitis, which in turn can evolve into cirrhosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
11180“…Strong CD8(+) T-cell infiltration, high mutation burden, and expression of exogenous viruses [Epstein-Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis C virus (HCV)] or endogenous retrovirus (ERV3-2) were associated with over-expression of IDO-1 in most cancer types, IDO-2 in many cancer types, and TDO-2 in a few cancer types. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto